Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States

Vox Sanguinis

Volumn 103, Issue 1, 2012, Pages 89-90

  Baylis, S A ^a   Gartner T ^b   Nick, S ^a   Ovemyr, J ^c   Blumel J ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

^b Octapharma   (Germany)

^c Octapharma   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS RNA;

BLOOD DONOR; GENE AMPLIFICATION; GENOTYPING TECHNIQUE; GERMANY; HEPATITIS E VIRUS; INFECTION RATE; LETTER; MOLECULAR DIAGNOSIS; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCREENING; SEROLOGY; SWEDEN; UNITED STATES; VIRAL CONTAMINATION; VIRUS LOAD; VIRUS STRAIN;

BLOOD DONORS; GERMANY; GREAT BRITAIN; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; RNA, VIRAL; SWEDEN;

EID: 84860289619     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2011.01583.x     Document Type: Letter

References (5)

1. Baylis SA, Mizusawa S, Okada Y, et al.: Collaborative study to establish as World Health Organization international standard for hepatitis E virus RNA for nucleic acid amplification technology (NAT)-based assays. 2011; WHO/BS/2011.2175.
2. Sakata H, Matsubayashi K, Takeda H, et al.: A nationwide survey for hepatitis E virus prevalence in Japanese blood donors with elevated alanine aminotransferase. Transfusion 2008; 48:2568-2576.
3. Ijaz S, Szypulska R, Tettmar KI, et al.: Detection of hepatitis E virus RNA in plasma mini-pools from blood donors in England. Vox Sang 2011; 102: pp. 272.
4. Baylis SA, Koc O, Nick S, et al.: Widespread distribution of hepatitis E virus in plasma fractionation pools. Vox Sang 2011; 102:182-183.
5. Renou C, Pariente A, Cadranel JF, et al.: Clinically silent forms may partly explain the rarity of acute autocthonous genotype 3c hepatitis E infection in France. J Clin Virol 2011; 51:139-141.